X hits on this document

Word document

Education and Training - page 19 / 23





19 / 23

Michael H. Allen, M. D.

March 2005

Patients (Abbott Laboratories M95-305).  Principal Investigator.

Comparison of the Safety and Efficacy of Depakote and Zyprexa in the Treatment of Bipolar Disorder (Abbott M99-045).  Principal Investigator.

Safety and Efficacy of Depakote as Combination Therapy in the Treatment of Psychosis Associated with Schizophrenia (Abbott Laboratories M99-010).  Principal Investigator.  

Risperidone Depot (Microspheres) vs Placebo in the Treatment of Subjects with Schizophrenia or Schizoaffective Disorder (Janssen RIS-USA-121).  Principal Investigator.

Systematic Treatment Enhancement Program for Bipolar Disorder  (NIMH-DS-0098)  Principal Investigator.

A Controlled Trial of the Efficacy of Rapid Initial Dose Escalation of Olanzapine to Treat Acute Behavioral Agitation in Schizophrenia and Bipolar I Disorder (Lilly F1D-US-HGIY).  Principal Investigator.

Rocky Mountain Clinical Trial Node (NIDA DA-99-004).  Scientific Advisory Committee.

Randomized Trial of Oral Risperidone Versus Intramuscular Haloperidol in the Emergency Treatment of Acute Psychosis (Janssen RIS-USA-235).  Consultant.

Efficacy and Safety of Flexible Doses of Risperidone vs. Placebo or Divalproex Sodium in the Treatment of Manic or Mixed Episodes… (Janssen RIS-USA-240, 241).  Investigator.

Multicenter Randomized, Double-Blind Study of Flexible Doses of Aripiprazole versus Perphenazine in the Treatment of Patients with Treatment-Resistant Schizophrenia (Bristol Meyers Squibb CN 138-032).  Investigator.

Randomized, Double-Blind Study of the Safety and Efficacy of Depakote ER plus Atypical Antipsychotic vs. Atypical Antipsychotic Alone in the Treatment of Schizophrenia.  (Abbott Laboratories M02-547).  Subinvestigator.  

A Double Blind Randomized Study Comparing Intramuscular Olanzapine Depot With Placebo in the Treatment of Patients With Schizophrenia (Lilly F1D-MC-HGJZ). Investigator.  

An Open-Label Study of Intramuscular Olanzapine Depot in Patients with Schizophrenia or Schizoaffective Disorder (Lilly F1D-MC-HGKB).  Investigator.

A multicenter, open-label, flexible-dose, parallel-group evaluation of the cataractogenic potential of quetiapine fumarate (SEROQUEL) and risperidone (RISPERDAL) in the long-term treatment of subjects with schizophrenia or schizoaffective disorder (AstraZeneca CLEARS 5077IL/0089).  Subinvestigator.

A Multicenter, Randomized, Double-Blind, Placebo Controlled Study of Aripiprazole Monotherapy in the Treatment of Acutely Manic Patients with Bipolar I Disorder.  Bristol-Meyers Squibb CN138125.  Subinvestigator.

Selected Expert Testimony

Custody.  Edwin C. Rendall v. Carol W. Rendall.  Circuit Court, Montgomery County,


Document info
Document views39
Page views39
Page last viewedTue Oct 25 07:08:23 UTC 2016